Cerebellum’s Pediatrix Medical MD Stock Holding History

Cerebellum’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11,179	Closed	-$282K	–	474
2019 Q2	$282K	Hold	11,179	–	–	0.23%	330
2019 Q1	$304K	Buy	11,179 +6,010	+116%	+$202K	0.26%	295
2018 Q4	$171K	Buy	5,169 +4,266	+472%	+$172K	0.12%	320
2018 Q3	$42K	Sell	903 -3,035	-77%	-$139K	0.07%	358
2018 Q2	$170K	Buy	3,938 +655	+20%	+$31.4K	0.28%	252
2018 Q1	$183K	Buy	+3,283	New	+$180K	0.23%	228

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Cerebellum's MD Position: Q3 2019 in Review

Cerebellum sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 11,179 shares — an estimated $282K sold.

Cerebellum first reported a position in MD in Q1 2018 and held it in 6 quarters. The position peaked at $304K in Q1 2019. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

Cerebellum reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
Cerebellum sold 11,179 Pediatrix Medical shares in Q3 2019, an estimated $282K.
Cerebellum first reported a position in Pediatrix Medical in Q1 2018 and held it in 6 quarters.
Cerebellum's Pediatrix Medical position peaked at $304K in Q1 2019.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Cerebellum's 13F filing for Q3 2019, filed 7 Oct 2019.